Professor Graham Richards C.B.E, MA, D.Phil, D.Sc., C.Chem, FRSC
Prof Graham Richards is a former Head of Chemistry at the University of Oxford and a council member at both the Royal Society of Chemistry & the Royal Institution. He has authored 300 scientific articles & 15 books, and has been recognized with numerous awards, including the Mullard Award, Lord Lloyd of Kilgerran Prize, the Italgas Prize & the Award of the American Chemical Society for Computers in Chemical and Pharmaceutical Research. His business ventures include co-founding Oxford Molecular, and helping to establish Oxford’s technology transfer office, Isis Innovations.
Sir Gregory Winter, FRS
Sir Gregory Winter graduated from Trinity College in 1973 and will become Master of the College in October 2012. He is a genetic engineer and best known for his research and inventions relating to therapeutic antibodies. His research career was based at the Medical Research Council’s Laboratory of Molecular Biology in Cambridge, and he was until recently the Deputy Director. He has won numerous scientific awards, and also founded three biotech companies: Cambridge Antibody Technology in 1989 (bought by AstraZeneca), Domantis in 2000 (bought by GSK) and Bicycle Therapeutics in 2009.
Professor Hagan Bayley PhD, FRSC, FRS
Prof Bayley is the Professor of Chemical Biology at the University of Oxford. He enjoys working at the interface of chemistry and biology by, for example, developing techniques for protein modification that have applications in both basic science and biotechnology. Professor Bayley founded Oxford Nanopore Technology, which spun from the University of Oxford in 2005. To date, the Company has raised nearly £75 million in six rounds of private funding, from a combination of private and institutional investors.
Professor C R Lowe, OBE, FREng, FInstP, FRSC
Chris Lowe is a biochemist turned polymath who works in the Department of Chemical Engineering & Biotechnology in the area of healthcare biotechnology. He is involved in research ranging from fundamental science to strategic applied science across multiple disciplines and has won a number of national and international prizes including two Queen’s awards, the “Most Entrepreneurial Scientist of the UK” and the BBSRC Commercial Innovator of the Year in 2011. He has been the driving force for the establishment of 11 spin-out companies.
Dr Marc Ventresca
Dr Marc Ventresca is an organisational and economic sociologist who teaches strategy, leadership and organisation theory at Oxford’s Saïd Business School with a focus on innovation and on how new markets get built. He also works as Senior Scholar with Center for Innovation and Communication at Stanford University. Marc holds a lead faculty role in research and teaching initiatives focused on innovation and entrepreneurship. His research investigates governance innovation among global financial markets, entrepreneurial leadership in knowledge- and information-intensive organisations, and value creation in emerging ecosystem services markets.
Simcha is an Assistant Professor (Lecturer) in Management Science and Innovation at University College London. He is a principal investigator on a number of research projects that focus on enhancing our understanding of the innovative and competitive dynamics governing new science-based industries in fields such as biotechnology. Simcha’s work has been published in international management journals such as Industrial and Corporate Change and Research Policy as well as practitioner oriented publications such as Nature Biotechnology. Simcha was elected Honorary Cambridge University European Trust Scholar and was awarded several grants and awards for his research including the first prize in the PRIME Early Career Competition and a DIME WP European Framework Grant for qualitative research on university entrepreneurship.